Marsh McLennan (MRSH) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for May 15, 2025, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote by May 14, 2025, or May 12, 2025, for plan shares.
Voting matters and shareholder proposals
Election of eleven directors is up for shareholder vote, with board recommending approval for all nominees.
Advisory (nonbinding) vote on named executive officer compensation is included.
Ratification of the selection of the independent registered public accounting firm is proposed.
Approval of the amended and restated 2020 Incentive and Stock Award Plan is on the agenda.
Board of directors and corporate governance
Eleven director nominees are listed for election at the annual meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Marsh McLennan
- 2025 revenue up 10%, adjusted EPS up 9%, and $2.0B in share repurchases.MRSH
Q4 202527 Feb 2026 - Q2 revenue up 6%, EPS up 10%, margin 29%, and dividend raised 15% amid robust growth.MRSH
Q2 20243 Feb 2026 - Q3 revenue up 6%, strong segment growth, and $7.75B McGriff acquisition announced.MRSH
Q3 202419 Jan 2026 - Strong 2024 growth, record acquisitions, and margin expansion set up a positive 2025 outlook.MRSH
Q4 20249 Jan 2026 - Q1 2025 revenue up 9%, adjusted EPS up 5%, with strong segment growth and capital returns.MRSH
Q1 202519 Dec 2025 - Strong 2024 results, robust governance, and key votes on directors, pay, auditor, and equity plan.MRSH
Proxy Filing1 Dec 2025 - Q2 2025 delivered 12% revenue growth, 11% EPS gain, and a 10% dividend increase.MRSH
Q2 20255 Nov 2025 - Q3 revenue up 11%, adjusted EPS up 11%, Thrive targets $400M savings, rebranding to Marsh.MRSH
Q3 202520 Oct 2025